Osteoclasts have been found to influence myeloma progression via direct crosstalk or release of distinct cytokines including IL-6, IL-3, macrophage inflammatory protein 1 alpha (MIP1α) or expression of receptor activator of NF-κB ligand (RANKL) (74). This evidence concerns the gene IL6 and plasma cell myeloma.